The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

A single platform for agents and property marketers to order and publish MLS-ready 3D tours, photos, videos, floor plans, and ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

The goals of physical therapy and chiropractic care are similar: to help you move better with less pain after an injury or surgery. The reasons for seeing one over the other depend on the nature of ...

Collins, along with Matthew Lau ’25, developed the affordable CRISPRKit to make CRISPR gene-editing technology accessible to high school students underrepresented in the sciences. The kit was ...

Free online therapy services are often volunteer-based and are not for people who have severe mental health concerns. However, there are options for low cost therapy. Our roundup shares some of ...

Ozone therapy is a controversial alternative medicine practice that involves using ozone gas to fight disease. Currently, there is not enough evidence to conclude it is effective or safe for ...

Copyright 2025 The Associated Press. All Rights Reserved. Chicago Chess Records producer Gene Barge attends a screening of the film “Cadillac Records,” about ...

Sometimes, however, the mechanism is far more covert, whereby subtle changes in gene expression or the genetic code itself ... “I have likened [Na v 1.7 and Na v 1.8] to a fuse and a firecracker,” ...

“Every gene therapy company should optimize and develop every technology in their arsenal of viral vectors,” advises Alexandria “Zandy” Forbes, PhD, president and CEO MeiraGTx. She ...

The Gene Therapy Centre is designed to address the growing demand for innovative treatments for SMA and DMD. It plans to expand the service in the future for other rare and complex genetic diseases.

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.